RDNT: RadNet, Inc. Stock

by  •  • Comments Off on RDNT: RadNet, Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 3,512.92
Enterprise Value ($M) 4,183.06
Book Value ($M) 813.36
Book Value / Share 11.03
Price / Book 4.32
NCAV ($M) -1,297.84
NCAV / Share -17.61
Price / NCAV -2.71

Profitability (mra)
Return on Invested Capital (ROIC) 0.00
Return on Assets (ROA) 0.00
Return on Equity (ROE) 0.01

Liquidity (mrq)
Quick Ratio 1.32
Current Ratio 1.32

Balance Sheet (mrq) ($M)
Current Assets 579.28
Assets 2,690.47
Liabilities 1,877.11
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,616.63
Operating Income 96.95
Net Income 3.04
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 220.86
Cash from Investing -201.47
Cash from Financing 195.63

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Beck Mack & Oliver Llc 4.80 0.28
02-13 13G/A Vanguard Group Inc 6.27 22.75
01-23 13G/A BlackRock Inc. 13.10 27.49

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q
2023-05-10 10-Q Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 71,007 300,331 23.64
2024-04-17 71,128 328,151 21.68
2024-04-16 48,574 277,366 17.51
2024-04-15 53,249 166,603 31.96

(click for more detail)

Similar Companies
CSTL – Castle Biosciences, Inc. FLGT – Fulgent Genetics, Inc.
PSNL – Personalis, Inc. SERA – Sera Prognostics, Inc.
VCYT – Veracyte, Inc.


Financial data and stock pages provided by
Fintel.io